South Dakota Investment Council’s Enanta Pharmaceuticals ENTA Stock Holding History

South Dakota Investment Council’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,536	Closed	-$87K	–	592
2021 Q3	$87K	Sell	1,536 -26,000	-94%	-$1.29M	﹤0.01%	567
2021 Q2	$1.21M	Buy	27,536 +10,790	+64%	+$528K	0.02%	441
2021 Q1	$826K	Buy	16,746 +9,846	+143%	+$491K	0.01%	498
2020 Q4	$290K	Hold	6,900	–	–	0.01%	563
2020 Q3	$316K	Hold	6,900	–	–	0.01%	533
2020 Q2	$346K	Hold	6,900	–	–	0.01%	513
2020 Q1	$355K	Hold	6,900	–	–	0.01%	482
2019 Q4	$426K	Sell	6,900 -1,900	-22%	-$118K	0.01%	509
2019 Q3	$529K	Buy	8,800 +8,000	+1,000%	+$594K	0.01%	520
2019 Q2	$68K	Hold	800	–	–	﹤0.01%	590
2019 Q1	$76K	Buy	+800	New	+$71.8K	﹤0.01%	587

Other funds holding ENTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

South Dakota Investment Council's ENTA Position: Q4 2021 in Review

South Dakota Investment Council sold out of Enanta Pharmaceuticals (ENTA) in Q4 2021, closing a stake of 1,536 shares — an estimated $87K sold.

South Dakota Investment Council first reported a position in ENTA in Q1 2019 and held it in 11 quarters. The position peaked at $1.21M in Q2 2021. 180 funds tracked by Wall St. Rank hold ENTA as of Q4 2021.

South Dakota Investment Council reported no remaining Enanta Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
South Dakota Investment Council sold 1,536 Enanta Pharmaceuticals shares in Q4 2021, an estimated $87K.
South Dakota Investment Council first reported a position in Enanta Pharmaceuticals in Q1 2019 and held it in 11 quarters.
South Dakota Investment Council's Enanta Pharmaceuticals position peaked at $1.21M in Q2 2021.
180 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2021.

Based on South Dakota Investment Council's 13F filing for Q4 2021, filed 8 Feb 2022.